Search results
What are alternatives to Ozempic and Wegovy and are they safe?
Medical Xpress· 2 hours agoThe copycat drugs are made by specialized pharmacies known as compounding pharmacies, which are allowed by the U.S. Food and Drug Administration to make ...
Hims & Hers Is Now Selling Semaglutide: Here's What You Should Know
Verywell Health via Yahoo Finance· 6 days agoCustomers who are eligible for Hims & Hers’ GLP-1 medication will receive drugs with the same active...
Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.
Barrons.com· 5 days agoA plan by Hims & Hers Health to sell legal copies of Novo Nordisk weight loss drug Wegovy is drawing...
Drugs advertised as alternatives to Ozempic, Wegovy posing health risks
WCVB Boston· 7 days agoAs drugs such as Wegovy and Ozempic become harder to get, 5 Investigates found that some people...
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 6 days agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...
Hims & Hers Now Selling Off-Brand Ozempic, Wegovy for $199
Healthline· 5 days agoHims & Hers is now selling compounded semaglutide for weight loss. Compounded medications undergo...
Hims & Hers will sell knock-off Ozempic for $199 — and it won’t be approved by FDA
NY Post via Yahoo Finance· 4 days agoCompounding medications are commonly used when a patient is allergic to an ingredient in a...
The truth behind new weight loss drugs
KARE 11 Minneapolis-St. Paul· 5 days agoYou’ve probably heard about those popular drugs being used for weight loss. Originally, they were made to fight diabetes, then they were prescribed for...
Louisiana seeks more abortion pill controls
Politico· 6 days agoNovo Nordisk said that compounding pharmacies are getting semaglutide from other entities. “Novo Nordisk...Reisinger said the company is partnering with ...
Hims & Hers Stock Spikes. It’s Taking on Big Pharma With Cheap Obesity Shots.
Barrons.com· 7 days agoA relatively small telehealth company that recently went public wants to take a slice of the big...